Facial Dermatoses
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Nodular Elastoidosis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
MACULAR DEGENERATION, AGE-RELATED, 15
|
disease |
|
Disease or Syndrome
|
1
|
1
|
0.600 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Decreased serum complement C9
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
C9 Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases
|
Disease or Syndrome
|
2
|
5
|
0.750 |
strong |
1.000 |
8 |
5
|
1998 |
2017 |
Favre-Racouchot Syndrome
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Meningitis, Meningococcal, Serogroup A
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Meningitis, Meningococcal, Serogroup B
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Meningitis, Meningococcal, Serogroup C
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Meningitis, Meningococcal, Serogroup Y
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Meningitis, Meningococcal, Serogroup W-135
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Narcotic Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Narcotic Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
7
|
1
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Opioid-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
12
|
23
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Opiate Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Opioid abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Meningococcal meningitis
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
17
|
3
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Antibody Deficiency Syndrome
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
21
|
|
0.300 |
None |
1.000 |
2 |
|
1998 |
2001 |
Complement deficiency disease
|
group |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
42
|
|
0.310 |
strong |
1.000 |
2 |
|
1998 |
1999 |
exudative macular degeneration
|
disease |
Eye Diseases
|
Disease or Syndrome
|
49
|
69
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Norrie disease
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Nervous System Diseases
|
Congenital Abnormality
|
55
|
28
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Aspartate aminotransferase measurement
|
phenotype |
|
Laboratory Procedure
|
57
|
76
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Dermatomyositis, Childhood Type
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
62
|
1
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Opiate Addiction
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
81
|
46
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Geographic Atrophy
|
disease |
Eye Diseases
|
Disease or Syndrome
|
85
|
81
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |